Samsara Bio Capital, LLC Sells in Q3 2024

Samsara Bio Capital, LLC

  • $173 Million
  • Q3 2024
Stock Shares change Price Range Shares Held Trade History
ELYM
Eliem Therapeutics, Inc.

Healthcare
-652K
- 20.0%
$4.98 - $8.93 $3.25M - $5.82M
2.61M $13.3M
JANX
Janux Therapeutics, Inc.

Healthcare
-22.5K
- 50.0%
$35.29 - $50.26 $795K - $1.13M
22.5K $1.02M
DAWN
Day One Biopharmaceuticals, Inc.

Healthcare
-49.1K
- 25.0%
$12.72 - $16.03 $625K - $787K
147K $2.05M
Contineum Therapeutics Inc
-1
- -0.0%
N/A
589K $0
VRNA
Verona Pharma PLC

Healthcare
-152K
- 43.82%
$15.46 - $30.16 $2.35M - $4.59M
195K $5.62M
ACLX
Arcellx, Inc.

Healthcare
-100K
- 22.04%
$50.91 - $86.61 $5.09M - $8.66M
354K $29.5M
Activity Summary
Buys All Purchases 4 New Holdings 3 Increased Positions 1 Sells All Sells 6 Reductions 6 Sold out 0 Options Calls 0 Puts 0
Track This Portfolio

Track Samsara Bio Capital, LLC Portfolio

Follow Samsara Bio Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samsara Bio Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email